CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea
McEvoy, R. Doug
Antic, Nick A.
White, David P.
Grunstein, Ron R.
Anderson, Craig S.
SAVE Investigators and Coordinators
MetadataShow full item record
Background Obstructive sleep apnea is associated with an increased risk of cardiovascular events; whether treatment with continuous positive airway pressure (CPAP) prevents major cardiovascular events is uncertain. Methods After a 1-week run-in period during which the participants used sham CPAP, we randomly assigned 2717 eligible adults between 45 and 75 years of age who had moderate-to-severe obstructive sleep apnea and coronary or cerebrovascular disease to receive CPAP treatment plus usual care (CPAP group) or usual care alone (usual-care group). The primary composite end point was death from cardiovascular causes, myocardial infarction, stroke, or hospitalization for unstable angina, heart failure, or transient ischemic attack. Secondary end points included other cardiovascular outcomes, health-related quality of life, snoring symptoms, daytime sleepiness, and mood. Results Most of the participants were men who had moderate-to-severe obstructive sleep apnea and minimal sleepiness. In the CPAP group, the mean duration of adherence to CPAP therapy was 3.3 hours per night, and the mean apnea–hypopnea index (the number of apnea or hypopnea events per hour of recording) decreased from 29.0 events per hour at baseline to 3.7 events per hour during follow-up. After a mean follow-up of 3.7 years, a primary end-point event had occurred in 229 participants in the CPAP group (17.0%) and in 207 participants in the usual-care group (15.4%) (hazard ratio with CPAP, 1.10; 95% confidence interval, 0.91 to 1.32; P=0.34). No significant effect on any individual or other composite cardiovascular end point was observed. CPAP significantly reduced snoring and daytime sleepiness and improved health-related quality of life and mood. Conclusions Therapy with CPAP plus usual care, as compared with usual care alone, did not prevent cardiovascular events in patients with moderate-to-severe obstructive sleep apnea and established cardiovascular disease.
Is part ofThe New England Journal of Medicine, 2016, vol. 375, núm. 10, p. 919-931
European research projects
Showing items related by title, author, creator and subject.
Effects of Ethnicity on the Prevalence of Obstructive Sleep Apnoea in Patients with Acute Coronary Syndrome: A Pooled Analysis of the ISAACC Trial and Sleep and Stent Study. Koo, Chieh-Yang; Sánchez de la Torre, Alicia; Loo, Germaine; Sánchez de la Torre, Manuel; Zhang, Junjie; Durán-Cantolla, Joaquín; Li, Ruogu; Mayós Pérez, Mercè; Sethi, Rithi; Abad, Jorge; Drager, Luciano; Coloma, Ramón; Hein, Thet; Ho, Hee-Hwa; Jim, Man-Hong; Ong, Thun-How; Tai, Bee-Choo; Aldomá, Albina; Lee, Chi-Hang; Barbé Illa, Ferran (ElsevierAustralian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS)Cardiac Society of Australia and New Zealand (CSANZ), 2017)Objective: Obstructive sleep apnea (OSA) is an increasing yet under-recognized risk factor for acute coronary syndrome (ACS). We sought to determine the effects of ethnicity on the prevalence of OSA in patients presenting ...
Long-term Effect of CPAP Treatment on Cardiovascular Events in Patients With Resistant Hypertension and Sleep Apnea. Data From the HIPARCO-2 Study Navarro-Soriano, Cristina; Martínez-García, Miguel Angel; Torres, Gerard; Barbé Illa, Ferran; Sánchez de la Torre, Manuel; Caballero-Eraso, Candela; Lloberes, Patricia; Díaz Cambriles, Trinidad; Somoza, María; Masa, Juan F.; González, Mónica; Mañas, Eva; de la Pena, Mónica; García-Río, Francisco; Montserrat, Josep Maria; Muriel, Alfonso; Oscullo, Grace; García-Ortega, Alberto; Posadas, Tomás; Campos-Rodríguez, Francisco; Spanish Sleep Network (Elsevier, 2020)Background: There is some controversy about the effect of continuous positive airway pressure (CPAP) on the incidence of cardiovascular events (CVE). However, the incidence of CVE among patients with both obstructive sleep ...
Impact of obstructive sleep apnea on the levels of placental growth factor (PlGF) and their value for predicting short-term adverse outcomes in patients with acute coronary syndrome Barceló Bennasar, Antònia; Bauçà, Josep Miquel; Yañez, Aina; Fueyo, Laura; Gomez, Cristina; Peña, Mónica de la; Pierola, Javier; Rodriguez, Alberto; Sánchez de la Torre, Manuel; Abad, Jorge; Mediano, Olga; Amilibia, Jose; Masdeu, María José; Terán, Joaquin; Montserrat i Capdevila, Josep; Mayos, Mercè; Sánchez de la Torre, Alicia; Barbé Illa, Ferran (Public Library of Science, 2016)Background Placental growth factor (PlGF) induces angiogenesis and promotes tissue repair, and plasma PlGF levels change markedly during acute myocardial infarction (AMI). Currently, the impact of obstructive sleep apnea ...